CompletedNCT00312598
Weight and metabolic changes after switching to aripiprazole
About this title
Read the official source — NCT00312598Observational studyAges 18–65Schizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
Study information
Study start dateAugust 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- University of North Carolina, Chapel Hill
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00312598
- Official title
Show the full official title
Investigation of Body Mass Index, Body Composition, Resting Energy Expenditure, Respiratory Quotient and Metabolic Changes Following a Switch From Olanzapine, Quetiapine or Risperidone to Aripiprazole
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of North Carolina, Chapel Hill, a university.
Did this study involve medication?
Yes. The study involved medication, including Aripiprazole.
Who was this study for?
Listed age limits: 18 years to 65 years.
